antiretroviral-therapy

Documents about antiretroviral-therapy

• Data Sheet 1_Preferences of people living with HIV for treatment regimen attributes: a qualitative interview study.pdf#784688Figshare
• Data Sheet 2_Preferences of people living with HIV for treatment regimen attributes: a qualitative interview study.pdf#784689Figshare
• The effect of short-course antiretroviral therapy initiated in primary HIV-1 infection on interleukin-6 and D-dimer levels#342900UNSWorks Repository
• Prospective Multicenter Study of the Relationship Between Virological Effectiveness and Compliance in HIV-1-infected Patients Treated With Bictegravir#879654ClinicalTrials.gov
• A Study to Evaluate the Safety and Effects of Repeated Doses of 3BNC117-LS and 10-1074-LS on Persistent Viral Reservoirs in People Living With HIV and on Suppressive Antiretroviral Therapy#906256ClinicalTrials.gov
• Operational considerations for preventing the mother-to-child transmission (PMTCT) of HIV in the 2013 WHO consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection#466863WHO IRIS
• Optimizing Prevention and Care for Pregnant and Postpartum Adolescent Girls and Young Women With HIV in Tanzania#839249ClinicalTrials.gov
• Accelerating the development of affordable HIV drug resistance testing for use in low-and middle-income settings: report of a virtual meeting, 27 January 2025#155915WHO IRIS
• Boceprevir (BOC) and Telaprevir (TPV) therapeutic drug monitoring in HCV and HIV-HCV infected patients treated with triple therapy Ribavirine/Peg-interferon/Boceprevir or Telaprevir: impact of the antiretroviral (ARV) treatment#442634HAL Science
• An Open-Label Study to Evaluate the Efficacy and Safety of Amprenavir (141W94) and Abacavir Combination Therapy in Protease Inhibitor Experienced Subjects With HIV-1 Infection Who Are Failing Their Current Antiretroviral Treatment Regimen#843766ClinicalTrials.gov
• A Study to Evaluate the Efficacy, Safety, and Tolerability of Using an Oral Once-daily 2 Drug Regimen Compared to an Oral Once-daily 3 Drug Regimen for the Treatment of Human Immunodeficiency Virus (HIV)-1 in Adults Who Have Not Previously Taken Antiretroviral Therapy#253159ClinicalTrials.gov
• Explainable AI-driven comparative analysis of machine learning models for predicting HIV viral nonsuppression in Ugandan patients : retrospective cross-sectional study#425973University of Pretoria Repository
• The Coach Mpilo Study: Evaluation of a Peer-led Intervention to Promote Engagement in HIV Care for Men Living With HIV#860366ClinicalTrials.gov
• Metabolic Liver Disease in Newly Diagnosed People Living With HIV (MASHIV-TR)#802659ClinicalTrials.gov
• Effectiveness and Safety of Darunavir/Cobicistat Plus Lamivudine Compared With Darunavir/Cobicistat Plus Tenofovir Alafenamide/Emtricitabine in Virologically Suppressed People Living With HIV at 24 and 48 Weeks of Follow-up#991856ClinicalTrials.gov
• A Randomized Trial of the Efficacy and Safety of a Strategy of Starting With Nelfinavir Versus Ritonavir Added to Background Antiretroviral (AR) Nucleoside Therapy in HIV-Infected Individuals With CD4+ Cell Counts Less Than or Equal to 200/mm3#966461ClinicalTrials.gov
• Evaluation of Problem Management Plus in Pregnant Women With HIV in Kenya#867891ClinicalTrials.gov
• Efficacy and Safety of Two Pharmacologic Strategies on Neurocognitive Impairment in HIV Infection. The TRIANT-TE Study#890641ClinicalTrials.gov
• Pilot Study to Evaluate the Decentralization of Patient Care Among People With HIV in Out-of-hospital Settings#900196ClinicalTrials.gov
• Trends of Morbidity and Mortality Among Thai HIV-infected and HIV-uninfected Patients: a Five-year Prospective Cohort Study#828165ClinicalTrials.gov
• Efficacy, Safety, and Tolerability of Ledipasvir/Sofosbuvir (LDV/SOF) Treatment for HIV/HCV Co-infected Participants Who Switch to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (E/C/F/TAF) or Emtricitabine/Rilpivirine/Tenofovir Alafenamide (F/R/TAF) Prior to LDV/SOF HCV Treatment#1045204ClinicalTrials.gov
• Safety,Effectiveness and Acceptability of Sino-implant II in DR#804296ClinicalTrials.gov
• A Study to Evaluate Efficacy, Safety and Tolerability in Antiretroviral Therapy (ART)-Experienced Participants of at Least 50 Years of Age Living With Human Immunodeficiency Virus (HIV) With Virologic Suppression Who Switch to DTG/3TC FDC From BIC/FTC/TAF#874737ClinicalTrials.gov
• Prevalence of Cigarette Smoking and Associated Factors in a Large Sample of HIV-Positive Patients Receiving Antiretroviral Therapy in Vietnam#651707eScholarship
• Study of Tenofovir Disoproxil Fumarate (TDF) for Prevention of HIV#853451ClinicalTrials.gov